Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 54
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Gen Intern Med ; 36(10): 3148-3158, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-33876379

RESUMO

BACKGROUND: Back pain is the most common cause of disability worldwide. While disability generally is associated with greater mortality, the association between back pain and mortality is unclear. Our objective was to examine whether back pain is associated with increased mortality risk and whether this association varies by age, sex, and back pain severity. METHODS: A systematic search of published literature was conducted using PubMed, Web of Science, and Embase databases from inception through March 2019. We included English-language prospective cohort studies evaluating the association of back pain with all-cause mortality with follow-up periods >5 years. Three reviewers independently screened studies, abstracted data, and appraised risk of bias using the Quality in Prognosis Studies (QUIPS) tool. A random-effects meta-analysis estimated combined odds ratios (OR) and 95% confidence intervals (CI), using the most adjusted model from each study. Potential effect modification by a priori hypothesized factors (age, sex, and back pain severity) was evaluated with meta-regression and stratified estimates. RESULTS: We identified eleven studies with 81,337 participants. Follow-up periods ranged from 5 to 23 years. The presence of any back pain, compared to none, was not associated with an increase in mortality (OR, 1.06; 95% CI, 0.97 to 1.16). However, back pain was associated with mortality in studies of women (OR, 1.22; 95% CI, 1.02 to 1.46) and among adults with more severe back pain (OR, 1.26; 95% CI, 1.14 to 1.40). CONCLUSION: Back pain was associated with a modest increase in all-cause mortality among women and those with more severe back pain.


Assuntos
Dor nas Costas , Pessoas com Deficiência , Adulto , Dor nas Costas/epidemiologia , Estudos de Coortes , Feminino , Humanos , Prognóstico , Estudos Prospectivos
3.
J Clin Gastroenterol ; 53(2): e84-e90, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-29351156

RESUMO

GOALS AND BACKGROUND: Two common endoscopic therapies for eradication of dysplastic Barrett's esophagus are radiofrequency ablation (RFA) and liquid nitrogen spray cryotherapy (LNC). There is no data comparing postprocedural pain. This study aimed to compare the incidence of postprocedural pain between the 2 ablation modalities. METHODS: This is a multicenter prospective study in which pain intensity scores and the presence of dysphagia were assessed immediately before and after treatment, 48 hours posttreatment and at 3 weeks posttreatment using validated instruments. RESULTS: Of 94 patients, 35 underwent LNC and 59 underwent RFA [36 with focal radiofrequency ablation (RFA-F) and 23 with circumferential radiofrequency ablation (RFA-C)]. Immediately posttreatment, patients in the LNC group reported an average Numeric Pain Scale score that was lower than in the RFA groups [LNC 0.41 vs. RFA-F 1.18 (P=0.026), LNC 0.41 vs. RFA-C 1.38 (P=0.010)]. These differences persisted at 48 hours posttreatment [LNC 0.76 vs. RFA-F 1.77 (P=0.013), LNC 0.76 vs. RFA-C 1.73 (P=0.018)]. The odds of pain after RFA were at least 5 times greater than after LNC [immediately posttreatment odds ratio, 5.26 (95% confidence interval, 1.85-14.29) and 48 h posttreatment odds ratio, 5.56 (95% confidence interval, 2.27-14.29)]. There was no difference in dysphagia after treatment in either group, at any time point (P=0.429). CONCLUSION: LNC was associated with less postprocedural pain when compared with RFA. These results help inform patients and physicians about the expected symptoms after ablative endotherapy.


Assuntos
Esôfago de Barrett/terapia , Crioterapia/métodos , Dor/epidemiologia , Ablação por Radiofrequência/métodos , Idoso , Idoso de 80 Anos ou mais , Esôfago de Barrett/patologia , Crioterapia/efeitos adversos , Transtornos de Deglutição/epidemiologia , Transtornos de Deglutição/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nitrogênio/administração & dosagem , Dor/etiologia , Estudos Prospectivos , Ablação por Radiofrequência/efeitos adversos
5.
N Engl J Med ; 373(3): 232-42, 2015 Jul 16.
Artigo em Inglês | MEDLINE | ID: mdl-26052984

RESUMO

BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS: In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. RESULTS: During a median follow-up of 3.0 years, there was a small difference in glycated hemoglobin levels (least-squares mean difference for sitagliptin vs. placebo, -0.29 percentage points; 95% confidence interval [CI], -0.32 to -0.27). Overall, the primary outcome occurred in 839 patients in the sitagliptin group (11.4%; 4.06 per 100 person-years) and 851 patients in the placebo group (11.6%; 4.17 per 100 person-years). Sitagliptin was noninferior to placebo for the primary composite cardiovascular outcome (hazard ratio, 0.98; 95% CI, 0.88 to 1.09; P<0.001). Rates of hospitalization for heart failure did not differ between the two groups (hazard ratio, 1.00; 95% CI, 0.83 to 1.20; P=0.98). There were no significant between-group differences in rates of acute pancreatitis (P=0.07) or pancreatic cancer (P=0.32). CONCLUSIONS: Among patients with type 2 diabetes and established cardiovascular disease, adding sitagliptin to usual care did not appear to increase the risk of major adverse cardiovascular events, hospitalization for heart failure, or other adverse events. (Funded by Merck Sharp & Dohme; TECOS ClinicalTrials.gov number, NCT00790205.).


Assuntos
Doenças Cardiovasculares/complicações , Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/efeitos adversos , Pirazinas/efeitos adversos , Triazóis/efeitos adversos , Administração Oral , Doenças Cardiovasculares/mortalidade , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Método Duplo-Cego , Quimioterapia Combinada , Seguimentos , Hemoglobinas Glicadas/análise , Cardiopatias/epidemiologia , Cardiopatias/etiologia , Insuficiência Cardíaca/etiologia , Hospitalização/estatística & dados numéricos , Humanos , Hipoglicemiantes/uso terapêutico , Estimativa de Kaplan-Meier , Pirazinas/uso terapêutico , Fosfato de Sitagliptina , Triazóis/uso terapêutico
7.
Mov Disord ; 31(12): 1772-1776, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27787939

RESUMO

INTRODUCTION: Task-specific focal dystonia (TSFD) is a disorder marked by degraded coordination in complex and exacting psychomotor tasks, such as musical performance. Its development is associated with prolonged and intensive practice of these tasks, but the etiology of TSFD is still unknown. The prevailing hypothesis was informed by findings in primates following repetitive simple grasping actions. This model implies, however, that complex manual tasks that yield more intricate and subtly varying sensorimotor patterns, as found in musical performance and handwriting, should be unlikely to lead to focal dystonia. HYPOTHESIS: We propose an alternative, "predictive-control" etiological hypothesis: When an overtaxed performer exhibits poorly controlled variability and errors in motor execution of a well-learned, high-precision task, predictive control processes deteriorate. This includes, in particular, those related to the formation or updating of a forward dynamic model that maps motor commands to predicted end-effector state, e.g. position and velocity of a key-pressing digit. CONCLUSION: Based on a critical literature review we argue that this results in the characteristic signs of focal dystonia, such as freezing, halting and inappropriate co-contraction specific to the task. Directions for future research are briefly discussed. © 2016 International Parkinson and Movement Disorder Society.


Assuntos
Distúrbios Distônicos/fisiopatologia , Função Executiva/fisiologia , Desempenho Psicomotor/fisiologia , Humanos
8.
Adv Exp Med Biol ; 875: 1113-21, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26611075

RESUMO

Active acoustic monitoring (AAM) can be used to study the behavioral response of marine life and to mitigate harm during high-danger anthropogenic activities. This has been done in fish studies for many decades, and there are now case studies in which AAM has been used for marine mammal monitoring as well. This includes monitoring where the ranges, AAM frequency of operation, and species are such that the AAM operation is completely outside the hearing range of the animals. However, it also includes AAM operations within the hearing range of marine life, although this does not necessarily that imply AAM is not a suitable tool. It is just not always possible to have a sufficient detection and tracking range and operate at a frequency outside the marine life hearing range. Likely, the best and most important application of AAM is when the anthropogenic activity to be conducted is temporary and presents a clear danger to aquatic life.


Assuntos
Acústica , Organismos Aquáticos/fisiologia , Monitoramento Ambiental , Animais , Conservação dos Recursos Naturais , Mamíferos/fisiologia
12.
Artigo em Alemão | MEDLINE | ID: mdl-25004380

RESUMO

At the morning of the sixth postoperative day after a complex cardiac surgery procedure, a patient accidentally received a subcutaneous injection of 450 mg Enoxaparin sodium (Clexane®, Sanofi GmbH, Frankfurt, Germany). A few hours later an excessive coagulopathy developed and necessitated the transfusion of allogenic blood products. The present case report describes and discusses our diagnostic and therapeutic approaches.


Assuntos
Anticoagulantes/efeitos adversos , Enoxaparina/efeitos adversos , Hemorragia Pós-Operatória/induzido quimicamente , Hemorragia Pós-Operatória/terapia , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Overdose de Drogas , Humanos , Masculino , Erros Médicos , Pessoa de Meia-Idade , Complicações Pós-Operatórias/induzido quimicamente , Complicações Pós-Operatórias/terapia
13.
Am Heart J ; 166(2): 217-223.e11, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23895803

RESUMO

Sodium glucose co-transporter 2 inhibition is a novel mode of treatment for type 2 diabetes mellitus (T2DM). The sodium glucose co-transporter 2 inhibitor canagliflozin lowered blood glucose, blood pressure, and body weight, with increased risk of urogenital infections in Phase 2 studies. Effects on macrovascular complications of diabetes remain to be determined. CANVAS is a double-blind, placebo-controlled trial designed to evaluate the effects of canagliflozin on the risk of cardiovascular disease and to assess safety and tolerability in patients with inadequately controlled T2DM and increased cardiovascular risk. The first of 2 planned phases randomized 4,330 individuals to placebo, canagliflozin 100 or 300 mg (1:1:1) with planned follow-up of about 2 years to substantiate potential cardiovascular protection by assessing key biomarkers and to achieve initial safety objectives. By the end of mid-September 2012, a total of 7174 patient-years of follow-up were accrued. Mean baseline age was 62 years, duration of diabetes 13 years; hemoglobin A1c 8.2%, fasting plasma glucose 9.3 mmol/L, and body mass index 32 kg/m(2). Of the participants, 34% are female and 57% had a history of atherosclerotic vascular disease. Participants will be followed up to achieve primary safety and tolerability objectives and to investigate secondary outcomes. The planned second phase will not be undertaken. CANVAS will define the effects of canagliflozin on biomarkers and provide data on cardiovascular safety against established regulatory parameters.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Glucosídeos/uso terapêutico , Hipoglicemiantes/uso terapêutico , Inibidores do Transportador 2 de Sódio-Glicose , Tiofenos/uso terapêutico , Idoso , Biomarcadores/sangue , Canagliflozina , Doenças Cardiovasculares/mortalidade , Método Duplo-Cego , Eletrocardiografia , Feminino , Glucosídeos/efeitos adversos , Humanos , Hipoglicemiantes/efeitos adversos , Masculino , Pessoa de Meia-Idade , Projetos de Pesquisa , Tiofenos/efeitos adversos
14.
J Biol Chem ; 286(6): 4742-8, 2011 Feb 11.
Artigo em Inglês | MEDLINE | ID: mdl-21051536

RESUMO

Proteins are the primary agents of function in biological systems, and their levels are critical control elements, reflecting the interplay between transcription, translation, and protein degradation. Here, we consider the role of microRNAs (miRNAs) in the post-transcriptional regulation of protein synthesis. To determine their impact on protein concentration, we constructed a mechanistic model consisting of four state variables and nine kinetic parameters that account for transcript sequestration and degradation via miRNA-mRNA complex formation. Our dynamical model predicts that, even when present in low copy number, miRNAs can exert potent effects on protein concentration. Sensitivity analysis of the steady-state solution indicates that miRNA synthesis commonly acts to fine-tune protein concentrations. However, the same analysis shows that for a small subset of miRNA-mRNA pairs characterized by slowly produced miRNAs, the miRNA synthesis rate is the dominant control element. Our model equations provide a tool to evaluate the importance of particular miRNAs on their target proteins and promote the development of miRNA-based therapies that target proteins associated with cancer, inflammation, and metabolic disorders.


Assuntos
MicroRNAs/biossíntese , Modelos Biológicos , Biossíntese de Proteínas , RNA Mensageiro/metabolismo , Animais , Humanos , Inflamação/metabolismo , Doenças Metabólicas/metabolismo , Neoplasias/metabolismo
17.
Crit Care ; 16(2): R69, 2012 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-22546374

RESUMO

INTRODUCTION: The correction of hypovolemia with acellular fluids results in acute normovolemic anemia. Whether the choice of the infusion fluid has an impact on the maintenance of oxygen (O2) supply during acute normovolemic anemia has not been investigated so far. METHODS: Thirty-six anesthetized and mechanically ventilated pigs were hemodiluted to their physiological limit of anemia tolerance, reflected by the individual critical hemoglobin concentration (Hbcrit). Hbcrit was defined as the Hb-concentration corresponding with the onset of supply-dependency of total body O2-consumption (VO2). The hemodilution protocol was randomly performed with either tetrastarch (6% HES 130/0.4, TS-group, n = 9), gelatin (3.5% urea-crosslinked polygeline, GEL-group, n = 9), hetastarch (6% HES 450/0.7, HS-group, n = 9) or Ringer's solution (RS-group, n = 9). The primary endpoint was the dimension of Hbcrit, secondary endpoints were parameters of central hemodynamics, O2 transport and tissue oxygenation. RESULTS: In each animal, normovolemia was maintained throughout the protocol. Hbcrit was met at 3.7 ± 0.6 g/dl (RS), 3.0 ± 0.6 g/dl (HS P < 0.05 vs. RS), 2.7 ± 0.6 g/dl (GEL, P < 0.05 vs. RS) and 2.1 ± 0.4 g/dl (TS, P < 0.05 vs. GEL, HS and RS). Hemodilution with RS resulted in a significant increase of extravascular lung water index (EVLWI) and a decrease of arterial oxygen partial pressure (paO2), and O2 extraction ratio was increased, when animals of the TS-, GEL- and HS-groups met their individual Hbcrit. CONCLUSIONS: The choice of the intravenous fluid has an impact on the tolerance of acute normovolemic anemia induced by acellular volume replacement. Third-generation tetrastarch preparations (e.g., HES 130/0.4) appear most advantageous regarding maintenance of tissue oxygenation during progressive anemia. The underlying mechanism includes a lower degree of extravasation and favourable effects on microcirculatory function.


Assuntos
Anemia/etiologia , Anemia/fisiopatologia , Hidratação/métodos , Hemodiluição/métodos , Hipovolemia/terapia , Análise de Variância , Animais , Volume Sanguíneo , Eletrocardiografia , Determinação de Ponto Final , Gelatina/farmacologia , Hemodinâmica/fisiologia , Hemoglobinas/análise , Derivados de Hidroxietil Amido/farmacologia , Soluções Isotônicas/farmacologia , Consumo de Oxigênio/fisiologia , Poligelina/farmacologia , Distribuição Aleatória , Análise de Regressão , Respiração Artificial , Solução de Ringer , Suínos
18.
Patterns (N Y) ; 3(12): 100634, 2022 Dec 09.
Artigo em Inglês | MEDLINE | ID: mdl-36569543

RESUMO

The origins of performance degradation in batteries can be traced to atomistic phenomena, accumulated at mesoscale dimensions, and compounded up to the level of electrode architectures. Hyperspectral X-ray spectromicroscopy techniques allow for the mapping of compositional variations, and phase separation across length scales with high spatial and energy resolution. We demonstrate the design of workflows combining singular value decomposition, principal-component analysis, k-means clustering, and linear combination fitting, in conjunction with a curated spectral database, to develop high-accuracy quantitative compositional maps of the effective depth of discharge across individual positive electrode particles and ensembles of particles. Using curated reference spectra, accurate and quantitative mapping of inter- and intraparticle compositional heterogeneities, phase separation, and stress gradients is achieved for a canonical phase-transforming positive electrode material, α-V2O5. Phase maps from single-particle measurements are used to reconstruct directional stress profiles showcasing the distinctive insights accessible from a standards-informed application of high-dimensional chemical imaging.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA